Pfizer Drug Combo Shows Breakthrough for Prostate Cancer

A new drug combination could help prostate cancer patients earlier in their fight, reducing the risk of tumor growth by more than expected in a major clinical trial.

The treatment targets a specific genetic mutation found in 1 in 4 metastatic prostate cancer cases.